Heart Transplant clinical trials

Explore recruiting heart transplant clinical trials.

Recruiting heart transplant studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Heart Transplant trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

DAPARHT: DAPAgliflozin for Renal protection in Heart Transplant recipients

Netherlands, Norway, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cytomegalovirus Prophylaxis with Letermovir in Heart Transplant Recipients: A Non-randomized Cohort Pilot Study

Slovenia

Therapeutic exploratory (Phase II) EU CTIS Study details

Interest of belatacept as a non-nephrotoxic immunosuppressive treatment in cardiac transplant patients at risk of chronic renal failure.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Gene Therapy for Danon Disease: A Phase 2 Study Evaluating the Efficacy and Safety of Intravenously Administered Adeno-Associated Virus Serotype 9 (rAAV9) Vector Containing the Human LAMP2 Isoform B Transgene (RP-A501; AAV9.LAMP2B) in Male Patients with Danon Disease

Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

ACAV: EFFICACY AND SAFETY OF ALIROCUMAB TO PREVENT EARLY CARDIAC ALLOGRAFT VASCULOPATHY IN RECENT HEART TRANSPLANT RECIPIENTS

Czechia

Therapeutic use (Phase IV) EU CTIS Study details

Effect at 3 months of early empagliflozin initiation in cardiogenic shock patients on mortality, rehospitalization, left ventricular ejection fraction and renal function. A randomized multicentric open trial. (EMPASHOCK)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Heart Transplant trials by city

Heart Transplant in Toronto Heart Transplant in Vancouver Heart Transplant in Montreal Heart Transplant in Calgary Heart Transplant in Edmonton Heart Transplant in Ottawa Heart Transplant in Winnipeg Heart Transplant in Quebec City Heart Transplant in Hamilton Heart Transplant in Kitchener Heart Transplant in London Heart Transplant in Halifax Heart Transplant in New York Heart Transplant in Los Angeles Heart Transplant in Chicago Heart Transplant in Houston

Heart Transplant clinical trials

Recruiting heart transplant studies right now

Postural Mobilization Compared to Noradrenaline Only in Off-Pump CABG Surgery

Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar: The AGTP II Trial

Comparative Analysis of Analgesic Approaches in the Early Period After CABG

Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With Subclinical Hypothyroidism

Multicenter Randomised Prospective Study for External Support Mesh VEST of Venous Coronary Grafts on the Right Territory

Effect of Nurse-Led Education and Tele-Interventions on Reducing Surgical Site Infections in Patients After Coronary Artery Bypass Surgery: a Clinical Trial

HIIT in Pediatric Heart Transplant Recipients (MedBIKE™)

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)

The Use of Coronary Displaced Flap and Deepithelialized Free Graft in the Treatment of Multiple Gingival Recessions

Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting

Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project

Also recruiting in Europe

DAPARHT: DAPAgliflozin for Renal protection in Heart Transplant recipients

Cytomegalovirus Prophylaxis with Letermovir in Heart Transplant Recipients: A Non-randomized Cohort Pilot Study

Interest of belatacept as a non-nephrotoxic immunosuppressive treatment in cardiac transplant patients at risk of chronic renal failure.

Gene Therapy for Danon Disease: A Phase 2 Study Evaluating the Efficacy and Safety of Intravenously Administered Adeno-Associated Virus Serotype 9 (rAAV9) Vector Containing the Human LAMP2 Isoform B Transgene (RP-A501; AAV9.LAMP2B) in Male Patients with Danon Disease

ACAV: EFFICACY AND SAFETY OF ALIROCUMAB TO PREVENT EARLY CARDIAC ALLOGRAFT VASCULOPATHY IN RECENT HEART TRANSPLANT RECIPIENTS

Effect at 3 months of early empagliflozin initiation in cardiogenic shock patients on mortality, rehospitalization, left ventricular ejection fraction and renal function. A randomized multicentric open trial. (EMPASHOCK)

Heart Transplant trials by city

Other conditions